4th Biennial Schizophrenia International Research Conference (April 2014)
“A novel Kv3 positive modulator augments gamma frequency oscillations in the mammalian neocortex in vitro” (Ben Mabrouk et al)
Publications
Tweets
Autifony Therapeutics and Boehringer Ingelheim to collaborate on novel ion channel target with potential in multipl… https://t.co/KMvOWVf9o5
Autifony Therapeutics regains rights to clinical stage Kv3 programme
https://t.co/rBHjjR7aC0
RT @singular_talent:Barbara Domayne-Hayman joined us on Careers in Discovery to talk startups, careers and more.
Barbara's experience… https://t.co/u0VXnvXlGI
Comments are closed.